Cedars-Sinai Medical Center
Collaborators: National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Johns Hopkins University
The EMMES Corporation
Information provided by: Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier: NCT00893360
Purpose
The purpose of this study is to determine whether giving cardiosphere-derived stem cells (CDCs) to patients with decreased heart function and/or a large amount of damaged muscle after a heart attack is safe. CDCs are cells grown from small biopsy samples taken from the heart. Giving a patient their own CDCs is an investigational procedure that has been approved by the Food and Drug Administration for this study. In addition to determining whether this treatment is safe, the study will also examine whether it can decrease the amount of heart muscle damage and/or improve heart function after a heart attack. The amount of heart muscle damage and the function of the heart directly affects prognosis (the predicted course of the disease), and the development of heart failure and other complications some patients experience after a heart attack.
For details about this trial go to
http://clinicaltrials.gov/ct2/show/NCT00893360?term=stem+cells&rank=7
Collaborators: National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Johns Hopkins University
The EMMES Corporation
Information provided by: Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier: NCT00893360
Purpose
The purpose of this study is to determine whether giving cardiosphere-derived stem cells (CDCs) to patients with decreased heart function and/or a large amount of damaged muscle after a heart attack is safe. CDCs are cells grown from small biopsy samples taken from the heart. Giving a patient their own CDCs is an investigational procedure that has been approved by the Food and Drug Administration for this study. In addition to determining whether this treatment is safe, the study will also examine whether it can decrease the amount of heart muscle damage and/or improve heart function after a heart attack. The amount of heart muscle damage and the function of the heart directly affects prognosis (the predicted course of the disease), and the development of heart failure and other complications some patients experience after a heart attack.
For details about this trial go to
http://clinicaltrials.gov/ct2/show/NCT00893360?term=stem+cells&rank=7